INTERPHEX 2021 Rescheduled Due to COVID-19
The event will be rescheduled for Oct. 19–21, 2021 at the Javits Center in New York City.
Reed Exhibitions announced on Nov. 18, 2020 that it is rescheduling its pharmaceutical industry event INTERPHEX—previously postponed to April 20–22, 2021 at the Javits Center in New York City—to Oct. 19–21, 2021 at the same venue due to the continuing spread of COVID-19.
“After extensive consultation and ongoing monitoring of the COVID-19 pandemic, we have made this decision with the wellbeing of all our customers and partners as our highest priority,” said Marie Browne, group vice president, Reed Exhibitions, in a company press release. “We recognize and appreciate how important INTERPHEX is to the industry and to businesses. We are developing additional channels and digital tools to complement the live event in order to serve the industry, support our loyal exhibitors, and to ensure our attendees have access to find the solutions they need to cost effectively develop and manufacture quality products.”
Source: Reed Exhibitions
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.
